A functional polymorphism in the promoter region ofGSTM1implies a complex role forGSTM1in breast cancer
- 19 February 2009
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 23 (7) , 2274-2287
- https://doi.org/10.1096/fj.08-124073
Abstract
Although a number of studies have been conducted to address the relation between a gene deletion polymorphism of glutathione S-transferase M1 (GSTM1) and breast cancer, no definite conclusion has been reached and no clear risk pattern has yet to emerge for GSTM1. We first conducted case-control studies that included 1920 subjects using a genotyping method allowing the definition of GSTM1-null (−/−), homozygous wild-type (+/+), and heterozygous (+/−) genotypes. The results show that GSTM1−/− confers an increased risk for breast cancer development compared with that in GSTM1-present individuals (+/+ and +/−), which was subsequently confirmed by a meta-analysis of all of the 41 relevant studies (odds ratio: 1.10, PGSTM1+/+ is also a risk genotype compared with GSTM1+/−. Furthermore, we identified a functional polymorphism in the GSTM1 promoter region associated with breast cancer. The variant allele modifies DNA binding to the AP-2α transcription factor, resulting in reduced promoter activity and mRNA expression. However, this low-activity allele is associated with reduced breast cancer risk. It seems that ∼60–70% expression from one allele of GSTM1 could suffice for protection against breast cancer; null activity and overactivity of GSTM1 are both disadvantageous. These results indicate a U-shaped association of GSTM1 with breast cancer, which challenges the linear gene-dosage effect of GSTM1 that was previously proposed. We recommend that a more complicated role for GSTM1 should be considered in breast cancer risk prediction.—Yu, K.D., Di, G.-H., Fan, L., Wu, J., Hu, Z., Shen, Z.-Z., Huang, W., Shao, Z.-M. A functional polymorphism in the promoter region of GSTM1 implies a complex role for GSTM1 in breast cancer.Keywords
Funding Information
- National Basic Research Program of China (2006CB910501)
- National Natural Science Foundation of China (30371580, 30572109)
- Science and Technology Commission of Shanghai Municipality (06DJ14004, 06DZ19504)
This publication has 35 references indexed in Scilit:
- Choline metabolism and risk of breast cancer in a population‐based studyThe FASEB Journal, 2008
- The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identifiedBreast Cancer Research and Treatment, 2007
- Development and Trends of Surgical Modalities for Breast Cancer in China: A Review of 16-Year DataAnnals of Surgical Oncology, 2007
- Estrogen Carcinogenesis in Breast CancerNew England Journal of Medicine, 2006
- G125A single-nucleotide polymorphism in the human BAX promoter affects gene expressionOncogene, 2005
- Combined effect of GSTM1, GSTT1, and COMT genotypes in individualBreast Cancer Research and Treatment, 2004
- Polygenic inheritance of breast cancer: Implications for design of association studiesGenetic Epidemiology, 2003
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001
- Glutathione S-transferase M1 Gene Deletion May Be Associated with Susceptibility to Certain Forms of SchizophreniaBiochemical and Biophysical Research Communications, 2001
- The Repressive Function of AP2 Transcription Factor on the Hepatocyte Growth Factor Gene PromoterBiochemical and Biophysical Research Communications, 2000